Reduce 15mg (100 tablets)

Product Code: Reduce15
Availability: In Stock

£98.00

Qty:

Active ingredient: Sibutramine
Content: 15mg
Average Dosage: 15mg/day

Reduce is used in combination with a weight loss program for the treatment of obesity and overweight.
Each capsule contains 15 mg of sibutramine. Reduce part of a slimming product that evokes a feeling of satiety. Reduce has been developed to provide food for overweight people to support you. Reduce is occupied by people who have a BMI of 27 or more. As an additional support to the body temperature is slightly increased by the ingestion of Reduce. You probably will not notice. With the increase of heat will also burn body fat. The effect is simply amazing. You are no doubt an exercise regime and even weight loss. You should order Reduce, if you really suffer from obesity. It is recommended to convert a diet low in fat.

Mode of action
Reduce inhibits the reuptake of serotonin and norepinephrine. This pharmacological action increase satiety and therefore reduce the desire for food.

Mechanism Of Action Inhibits reuptake of norepinephrine, serotonin and dopamine. May stimulate satiety center in the brain, resulting in the suppression of appetite. Inhibits the reuptake of serotonin (5.HT) nor adrenaline and to a lesser extent, dopamine in Vivo and in vitro M1 and M2 metabolites are pharmacologically active and are about 100 times more powerful than reuptake inhibitors of sibutramine has no effect on dopamine receptors, some thermogenic activity is evident at doses of 10mg apparent abuse potential lower in humans. Reduce (Sibutramine) produce its therapeutic effect by Norepinephrine, serotonin and inhibition of dopamine reuptake. Pharmaco Kinetics Reduce reaches maximum therapeutic concentration in 1.2hrs. Food delays the absorption by 3hrs. Approximately 77% of the single oral dose is absorbed. The state of equilibrium is reached in 4 days. Reduce (Sibutramine) is extensively bound and is rapidly and extensively distributed into tissues. It undergoes extensive metabolism is not first and foremost by cytochromep4503A4 isoenzyme. Approximately 85% of the drug eliminated through urine. Directions management of obesity, including weight loss and maintenance of weight loss and should be used in conjunction with a reduced calorie diet. The dosage recommended for obese patients with an initial BMI 30kg/m2 or 27kg/m2 in the presence of risk factors (eg, hypertension, diabetes, dyslipidemia). Initially 10mg of sibutramine is given once a day with or without food. If there is inadequate weight loss, the dose will be adjusted after four weeks for a total of 15-20 mg once a day.

Side Effects
They are common in early treatment with Reduce. These include palpitation, hypertension, flushing, abnormal appetite, constipation, nausea, sécherresse mouth, constipation, headache, taste disturbances, insomnia.